Dilution profile // every instrument, one screen, from SEC filings

Lifeward Ltd. (LFWD)

CIK 1607962 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGH$64.8M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
HIGHwarrants = 171% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW-95% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
MEDIUM~6.7 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-11-102026-08-12

Latest: 2.8M shares as of Aug 12, 2026 (10-Q). Share count fell from 73.1M to 4.5M between Feb 5, 2019 and May 8, 2019, a pattern consistent with a reverse split (roughly 1-for-16); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

TrancheWarrantsExercise priceTermNotes
Issuance Date Nine3.1M$5.4
Freestanding Warrants1.9M$5.4
Issuance Date Ten1.0M$0.0001
Issuance Date Seven333,328$7.8
Issuance Date Five151,514$33
Issuance Date Three95,314$168
Issuance Date One64,998$302.4
Issuance Date Eight20,000$9.75
Issuance Date Four11,437$213.68
Issuance Date Six9,088$41.25
Issuance Date Two7,800$384.56

Tranches exactly as the company dimensioned them in its 10-Q filed Aug 14, 2026. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.

Warrants outstanding: 4.8M underlying shares, as reported Jun 30, 2026 (10-Q).

Reported exercise price: $0.3 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $19.46B as of Dec 31, 2022.

Rough fully diluted estimate: 7.7M = 2.8M O/S + 4.8M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

NotePrincipalCarryingConv. priceRateIf converted
Convertible New Note$10.0Mnot tagged8%

Notes exactly as the company dimensioned them in its 10-Q filed Aug 14, 2026. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding2.8MAug 12, 2026
+ Issuance Date Nine (if exercised)3.1MJun 30, 2026
+ Freestanding Warrants (if exercised)1.9MMar 25, 2026
+ Issuance Date Ten (if exercised)1.0MJun 30, 2026
+ Issuance Date Seven (if exercised)333,328Jun 30, 2026
+ Issuance Date Five (if exercised)151,514Jun 30, 2026
+ Issuance Date Three (if exercised)95,314Jun 30, 2026
+ Issuance Date One (if exercised)64,998Jun 30, 2026
+ Issuance Date Eight (if exercised)20,000Jun 30, 2026
+ Issuance Date Four (if exercised)11,437Jun 30, 2026
+ Issuance Date Six (if exercised)9,088Jun 30, 2026
+ Issuance Date Two (if exercised)7,800Jun 30, 2026
Fully diluted estimate9.5M+236.6% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $64.8Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3Aug 3, 2026$14.3M registeredfiling →
S-3Apr 27, 2026$50.5M registeredfiling →
S-1Jun 20, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 5 executed · 3 registered.

EFFECTIVEAug 10, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDAug 3, 2026S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDJul 7, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
EFFECTIVEMay 12, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDApr 27, 2026S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDMar 25, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDFeb 25, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDJan 13, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
EFFECTIVEJan 6, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDJan 2, 2026S-3/A registration — capacity to sell shares, not a sale yetS-3/A
EXECUTEDNov 14, 2025Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDJun 26, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full LFWD workspace